Hypolipidaemic and anti-atherosclerotic effects of lupin proteins in a rabbit model

被引:50
|
作者
Marchesi, Marta [1 ]
Parolini, Cinzia [1 ]
Diani, Erika [1 ]
Rigamonti, Elena [1 ]
Cornelli, Lorena [1 ]
Arnoldi, Anna [2 ]
Sirtori, Cesare R. [1 ]
Chiesa, Giulia [1 ]
机构
[1] Univ Milan, Dept Pharmaceut Sci, I-20133 Milan, Italy
[2] Univ Milan, Dept Agrifood Mol Sci, I-20133 Milan, Italy
关键词
Lupinus albus; Protein isolates; Cholesterol; Atherosclerosis; Rabbits;
D O I
10.1017/S000711450894215X
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
The biological activities of a protein isolate from lupin (Lupinus albus) were studied in a rabbit model of atherosclerosis. Focal plaque development was induced at both common carotid arteries by perivascular injury. After surgery. animals were fed three different diets for 90d, all with 1% cholesterol. 15 % SFA and 20 % protein: the protein source was casein (CAS), lupin proteins (LUP) or 50 % CAS + 50 % LUP (CAS + LUP). Lower cholesterolaemia was detected in the LUP v. the CAS group at 60 and 90 d of treatment (- 40.3 and - 33-5 %, respectively; P<0-05). Cryosection analyses of the carotids indicated a significant reduction in focal lesion progression in the LUP v. the CAS group (-37.4%; P<0.05). In summary. in a rabbit model of atherosclerosis. a protein isolate from L. albus reduced cholesterolaemia and exerted a remarkable protective activity against atherosclerosis progression.
引用
收藏
页码:707 / 710
页数:4
相关论文
共 50 条
  • [1] Anti-atherosclerotic effects of konjac
    Yanai, Hidekatsu
    Adachi, Hiroki
    Katsuyama, Hisayuki
    Hamasaki, Hidetaka
    Sako, Akahito
    FUNCTIONAL FOODS IN HEALTH AND DISEASE, 2015, 5 (04): : 136 - 144
  • [2] Contribution of the WHHL rabbit, an animal model of familial hypercholesterolemia, to elucidation of the anti-atherosclerotic effects of statins
    Shiomi, Masashi
    Koike, Tomonari
    Ito, Takashi
    ATHEROSCLEROSIS, 2013, 231 (01) : 39 - 47
  • [3] Hyperlipidemic Rabbit Models for Anti-Atherosclerotic Drug Development
    Niimi, Manabu
    Chen, Yajie
    Yan, Haizhao
    Wang, Yao
    Koike, Tomonari
    Fan, Jianglin
    APPLIED SCIENCES-BASEL, 2020, 10 (23): : 1 - 19
  • [4] The hyperlipemic hamster, a model to study statins anti-atherosclerotic effects
    Stancu, C.
    Constantinescu, E.
    Botez, G.
    Sima, A.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 193 - 193
  • [5] Anti-atherosclerotic effect of geniposidic acid in a rabbit model and related cellular mechanisms
    Gao, Yu
    Chen, Zi-yu
    Liang, Xue
    Xie, Cong
    Chen, Yong-feng
    PHARMACEUTICAL BIOLOGY, 2015, 53 (02) : 280 - 285
  • [6] Challenges in Drug Development Targeting Anti-atherosclerotic Proteins
    Okuhira, Keiichiro
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2020, 140 (02): : 153 - 157
  • [7] Mechanisms Underlying the Anti-Atherosclerotic Effects of EGCG
    Wang, Lili
    Pan, Qun
    Tang, Chunlian
    CURRENT MOLECULAR MEDICINE, 2025,
  • [8] Anti-atherosclerotic effects of the hexapeptide angiotensin IV
    Vinh, Antony
    Widdop, Robert
    Gaspari, Tracey
    FASEB JOURNAL, 2008, 22
  • [9] ANTI-ATHEROSCLEROTIC EFFECTS OF SQUALENE SYNTHASE INHIBITORS
    Tavridou, A.
    Manolopoulos, V.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [10] Anti-atherosclerotic and renoprotective effects of rosuvastatin in a model of diabetes-accelerated atherosclerosis
    Jandeleit-Dahm, KAM
    Giunti, S
    Boolell, V
    Calkin, A
    Lassila, M
    Allen, TJ
    Cooper, ME
    DIABETOLOGIA, 2005, 48 : A410 - A411